|
1
|
de Vries AC, van Grieken NC, Looman CW,
Casparie MK, de Vries E, Meijer GA and Kuipers EJ: Gastric cancer
risk in patients with premalignant gastric lesions: A nationwide
cohort study in the Netherlands. Gastroenterology. 134:945–952.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tatsuta M, Iishi H, Nakaizumi A, Okuda S,
Taniguchi H, Hiyama T, Tsukuma H and Oshima A: Fundal atrophic
gastritis as a risk factor for gastric cancer. Int J Cancer.
53:70–74. 1993.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Uemura N, Okamoto S, Yamamoto S, Matsumura
N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ohata H, Kitauchi S, Yoshimura N, Mugitani
K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, et
al: Progression of chronic atrophic gastritis associated with
Helicobacter pylori infection increases risk of gastric cancer. Int
J Cancer. 109:138–143. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kanno T, Matsuki T, Oka M, Utsunomiya H,
Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, et al:
Gastric acid reduction leads to an alteration in lower intestinal
microflora. Biochem Biophys Res Commun. 381:666–670.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Inoue I, Kato J, Yoshimura N, Maeda Y,
Moribata K, Shingaki N, Deguchi H, Enomoto S, Maekita T, Ueda K, et
al: Elevated risk of recurrent colorectal neoplasia with
Helicobacter pylori-associated chronic atrophic gastritis: A
follow-up study of patients with endoscopically resected colorectal
neoplasia. Mol Clin Oncol. 1:75–82. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yu TY, Wei JN, Kuo CH, Liou JM, Lin MS,
Shih SR, Hua CH, Hsein YC, Hsu YW, Chuang LM, et al: The impact of
gastric Atrophy on the incidence of diabetes. Sci Rep.
7(39777)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Graham DY, Malaty HM, Evans DG Jr, Klein
PD and Adam E: Epidemiology of Helicobacter pylori in an
asymptomatic population in the United States. Effect of age, race,
and socioeconomic status. Gastroenterology. 100:1495–1501.
1991.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mégraud F, Brassens-Rabbé MP, Denis F,
Belbouri A and Hoa DQ: Seroepidemiology of Campylobacter pylori
infection in various populations. J Clin Microbiol. 27:1871–1973.
1989.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Official Statistics of Sweden: Cancer
Incidence in Sweden 2011. The National Board of Health and Welfare,
Stockholm, 2013.
|
|
11
|
Graham DY, Adam E, Klein PD, Evans DJ Jr,
Evans DG, Hazell SL, Alpert LC, Michaletz PA and Yoshimura HH:
Epidemiology of Campylobacter pylori infection. Gastroenterol Clin
Biol. 3:84B–88B. 1989.PubMed/NCBI
|
|
12
|
Asaka M, Kudo M, Kato M, Sugiyama T and
Takeda H: Review article: Long-term Helicobacter pylori
infection-from gastritis to gastric cancer. Aliment Pharmacol Ther.
12 (Suppl 1):S9–S15. 1998.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yamagata H, Kiyohara Y, Aoyagi K, Kato I,
Iwamoto H, Nakayama K, Shimizu H, Tanizaki Y, Arima H, Shinohara N,
et al: Impact of Helicobacter pylori infection on gastric cancer
incidence in a general Japanese population: The Hisayama study.
Arch Intern Med. 13:1962–1968. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shikata K, Doi Y, Yonemoto K, Arima H,
Ninomiya T, Kubo M, Tanizaki Y, Matsumoto T, Iida M and Kiyohara Y:
Population-based prospective study of the combined influence of
cigarette smoking and Helicobacter pylori infection on gastric
cancer incidence: The Hisayama study. Am J Epidemiol.
168:1409–1415. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tamura T, Morita E, Kondo T, Ueyama J,
Tanaka T, Kida Y, Hori Y, Inoue S, Tomita K, Okada R, et al:
Prevalence of Helicobacter pylori infection measured with urinary
antibody in urban area of Japan, 2008-2010. Nagoya J Med Sci.
74:63–70. 2012.PubMed/NCBI
|
|
16
|
Hirayama Y, Kawai T, Otaki J, Kawakami K
and Harada Y: Prevalence of Helicobacter pylori infection with
healthy subjects in Japan. J Gastroenterol Hepatol. 29 (Suppl
4):S16–S19. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Guarner J, Herrera-Goepfert R, Mohar A,
Sanchez L, Halperin D, Ley C and Parsonnet J: Interobserver
variability in application of the revised Sydney classification for
gastritis. Hum Pathol. 30:1431–1434. 1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eaton KA and Krakowka S: Chronic active
gastritis due to Helicobacter pylori in immunized gnotobiotic
piglets. Gastroenterology. 103:1580–1586. 1992.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Loffeld RJ, Werdmuller BF, Kusters JG and
Kuipers EJ: IgG antibody titer against Helicobacter pylori
correlates with presence of cytotoxin associated gene A-positive H.
pylori strains. FEMS Immunol Med Microbiol. 28:139–141.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Miki K, Ichinose M, Shimizu A, Huang SC,
Oka H, Furihata C, Matsushima T and Takahashi K: Serum pepsinogens
as a screening test of extensive chronic gastritis. Gastroenterol
Jpn. 22:133–141. 1987.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hirshiowitz BI: Pepsinogen: Its origins,
secretion and excretion. Physiol Rev. 37:475–511. 1957.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Samloff IM, Varis K, Ihamaki T, Siurala M
and Rotter JI: Relationships among serum pepsinogen I, serum
pepsinogen II, and gastric mucosal histology. A study in relatives
of patients with pernicious anemia. Gastroenterology. 83:204–209.
1982.PubMed/NCBI
|
|
23
|
Ichinose M, Yahagi N, Oka M, Ikeda H, Miki
K and Omata M: Screeening for gastric cancer in Japan. In: Wu GY,
Aziz K, eds. Cancer screening for common malignancies. Totowa, New
Jersey: Humana Press 87-102, 2001.
|
|
24
|
Agréus L, Kuipers EJ, Kupcinskas L,
Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen
M, Perez GP, et al: Rationale in diagnosis and screening of
atrophic gastritis with stomach specific plasma biomarkers. Scand J
Gastroenterol. 47:136–147. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Song H, Held M, Sandin S, Rautelin H,
Eliasson M, Söderberg S, Hallmans G, Engstrand L, Nyrén O and Ye W:
Increase in the prevalence of atrophic gastritis among adults age
35 to 44 years old in Northern Sweden between 1990 and 2009. Clin
Gastroenterol Hepatol. 13:1592–1600. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Muraki S, Oka H, Akune T, Mabuchi A, En-yo
Y, Yoshida M, Saika A, Suzuki T, Yoshida H, Ishibashi H, et al:
Prevalence of radiographic knee osteoarthritis and its association
with knee pain in the elderly of Japanese population-based cohorts:
The ROAD study. Osteoarthr Cartil. 17:1137–1143. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cancer Statistics. Cancer Information
Service, National Cancer Center, Japan (Vital Statistics of Japan,
Ministry of Health, Labour and Welfare). https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#pref_mortality.
Accessed August 5, 2022.
|
|
28
|
Yoshimura N, Muraki S, Oka H, Mabuchi A,
En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, et
al: Prevalence of knee osteoarthritis, lumbar spondylosis and
osteoporosis in Japanese men and women: The research on
osteoarthritis/osteoporosis against disability study. J Bone Miner
Metab. 27:620–628. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yoshimura N, Muraki S, Oka H, Kawaguchi H,
Nakamura K and Akune T: Cohort profile: Research on
osteoarthritis/osteoporosis against disability (ROAD) study. Int J
Epidemiol. 39:988–995. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yoshimura N, Oka H, Muraki S, Akune T,
Hirabayashi N, Matsuda S, Nojiri T, Hatanaka K, Ishimoto Y, Nagata
K, et al: Reference values for hand grip strength, muscle mass,
walking time, and one-leg standing time as indices for locomotive
syndrome and associated disability: The second survey of the ROAD
study. J Orthop Sci. 16:768–777. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kawai S, Arai K, Lin Y, Nishiyama T,
Sasakabe T, Wang C, Miwa H and Kikuchi S: Comparison of the
detection of Helicobacter pylori infection by commercially
available serological testing kits and the 13C-urea
breath test. J Infect Chemother. 25:769–773. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ichinose M, Miki K, Furihata C, Kageyama
T, Hayashi R, Niwa H, Oka H, Matsushima T and Takahashi K:
Radioimmunoassay of serum group I and group II pepsinogens in
normal controls and patients with various disorders. Clin Chim
Acta. 126:183–191. 1982.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lahner E, Zagari RM, Zullo A, Di Sabatino
A, Meggio A, Cesaro P, Lenti MV, Annibale B and Corazza GR: Chronic
atrophic gastritis: Natural history, diagnosis and therapeutic
management. A position paper by the Italian society of hospital
gastroenterologists and digestive endoscopists [AIGO], the italian
society of digestive endoscopy [SIED], the Italian society of
gastroenterology [SIGE], and the Italian society of internal
medicine [SIMI]. Dig Liv Dis. 51:1621–1632. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X,
Tian SB and Yan C: Significance of serum pepsinogens as a biomarker
for gastric cancer and atrophic gastritis screening: A systematic
review and meta-analysis. PLoS One. 10(e0142080)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Weck MN and Brenner H: Prevalence of
chronic atrophic gastritis in different parts of the world. Cancer
Epidemiol Biomarkers Prev. 15:1083–1094. 2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Karita M, Noriyasu A, Kosako E, Teramukai
S and Matsumoto S: Relationship between pepsinogen I&II and H.
pylori infection considered with grade of atrophy and
gastroduodenal diseases. Dig Dis Sci. 48:1839–1845. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Karita M, Teramukai S and Matsumoto S:
Risk of Helicobacter pylori transmission from drinking well water
is higher than that from infected intrafamilial members in Japan.
Dig Dis Sci. 48:1062–1067. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fujisawa T, Kumagai T, Akamatsu T,
Kiyosawa K and Matsunaga Y: Changes in seroepidemiological pattern
of Helicobacter pylori and hepatitis A virus over the last 20 years
in Japan. Am J Gastroenterol. 94:2094–2099. 1999.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kawai T, Yamamoto K, Fukuzawa M, Yamagishi
T, Yagi K, Fukuzawa M, Kataoka M, Kawakami K, Itoi T, Sakai Y, et
al: Helicobacter pylori infection and reflux esophagitis in young
and middle-aged Japanese subjects. J Gastroenterol Hepatol. 25
(Suppl 1):S80–S85. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Karnes WE Jr, Samloff IM, Siurala M, Kekki
M, Sipponen P, Kim SW and Walsh JH: Positive serum antibody and
negative tissue staining for Helicobacter pylori in subjects with
atrophic body gastritis. Gastroenterology. 101:167–174.
1991.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kokkola A, Kosunen TU, Puolakkainen P,
Sipponen P, Harkonen M, Laxen F, Virtamo J, Haapiainen R and
Rautelin H: Spontaneous disappearance of Helicobacter pylori
antibodies in patients with advanced atrophic corpus gastritis.
APMIS. 111:619–624. 2003.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Notsu T, Adachi K, Mishiro T, Fujihara H,
Toda T, Takaki S and Kinoshita Y: Prevalence of autoimmune
gastritis in individuals undergoing medical checkups in Japan.
Intern Med. 58:1817–1823. 2019.PubMed/NCBI View Article : Google Scholar
|
